Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Delayed Quote USD

MIRA Pharmaceuticals, Inc. (MIRA)

0.9942
+0.0732
+(7.95%)
At close: April 24 at 4:00:01 PM EDT
0.9700
-0.02
(-2.43%)
After hours: April 24 at 7:42:15 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
8,018.3280
8,018.3280
--
7,047.9400
2,152.1620
Operating Income
-8,018.3280
-8,018.3280
--
-7,047.9400
-2,152.1620
Net Non Operating Interest Income Expense
165.6690
165.6690
--
-10.2500
-24.3740
Pretax Income
-7,852.6590
-7,852.6590
--
-7,058.1900
-2,176.5360
Net Income Common Stockholders
-7,852.6590
-7,852.6590
--
-7,058.1900
-2,176.5360
Diluted NI Available to Com Stockholders
-7,852.6590
-7,852.6590
--
-7,058.1900
-2,176.5360
Basic EPS
-0.51
-0.51
-0.85
-0.40
-0.15
Diluted EPS
-0.51
-0.51
-0.85
-0.40
-0.15
Basic Average Shares
15,444.1490
15,444.1490
13,924.6190
17,750.6670
14,745.1700
Diluted Average Shares
15,444.1490
15,444.1490
13,924.6190
17,750.6670
14,745.1700
Total Expenses
8,018.3280
8,018.3280
--
7,047.9400
2,152.1620
Net Income from Continuing & Discontinued Operation
-7,852.6590
-7,852.6590
--
-7,058.1900
-2,176.5360
Normalized Income
-7,852.6590
-7,852.6590
--
-7,058.1900
-2,176.5360
Interest Expense
727.0390
--
--
10.2500
24.3740
Net Interest Income
165.6690
165.6690
--
-10.2500
-24.3740
EBIT
-8,018.3280
-8,018.3280
--
-7,047.9400
-2,152.1620
EBITDA
-8,018.3280
-8,018.3280
--
-7,047.9400
-2,152.1620
Net Income from Continuing Operation Net Minority Interest
-7,852.6590
-7,852.6590
--
-7,058.1900
-2,176.5360
Normalized EBITDA
-8,018.3280
-8,018.3280
--
-7,047.9400
-2,152.1620
12/31/2021 - 8/14/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers